Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Brain metastases are an increasing burden among breast cancer patients, particularly for those with HER2+ and triple negative (TN) subtypes. Mechanistic insight into the pathophysiology of brain metastases and preclinical validation of therapies has relied almost exclusively on intracardiac injectio...

Full description

Bibliographic Details
Main Authors:	María J. Contreras-Zárate, D. Ryan Ormond, Austin E. Gillen, Colton Hanna, Nicole L. Day, Natalie J. Serkova, Britta M. Jacobsen, Susan M. Edgerton, Ann D. Thor, Virginia F. Borges, Kevin O. Lillehei, Michael W. Graner, Peter Kabos, Diana M. Cittelly
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-11-01
Series:	Frontiers in Oncology
Subjects:	patient-derived xenograft brain metastases models breast cancer brain colonization triple negative HER2+
Online Access:	http://journal.frontiersin.org/article/10.3389/fonc.2017.00252/full

Similar Items

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
by: Malcolm Lim, et al.
Published: (2022-01-01)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
by: Chen Jiaxin, et al.
Published: (2022-10-01)

Management of Brain and Leptomeningeal Metastases from Breast Cancer
by: Alessia Pellerino, et al.
Published: (2020-11-01)

HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series
by: Gianpiero Fasola, et al.
Published: (2013-01-01)

Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02)
by: Claire Phillips, et al.
Published: (2024-04-01)

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
by: Eurydice Angeli, et al.
Published: (2024-04-01)

Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review
by: Giuseppina Rosaria Rita Ricciardi, et al.
Published: (2018-01-01)

Characterization of Treatments and Disease Course for Women with Breast Cancer Brain Metastases: 5-Year Retrospective Single Institution Experience
by: Chew S, et al.
Published: (2021-11-01)

Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
by: Wang C, et al.
Published: (2024-03-01)

Management Strategies for Large Brain Metastases
by: Nehaw Sarmey, et al.
Published: (2022-02-01)

Extrathoracic Metastases in Pleural Mesothelioma
by: Ibiayi Dagogo-Jack, MD, et al.
Published: (2023-09-01)

Effects of Whole-brain Radiotherapy Combined with Targeted Therapy on Improving Survival of HER2-positive Breast Cancer Patients with Brain Metastases
by: LI Zhensheng, et al.
Published: (2018-11-01)

Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis
by: Xingfa Huo, et al.
Published: (2023-02-01)

All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer – A phase II study
by: Hanan Shawky, et al.
Published: (2014-12-01)

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis
by: Inge M. Werter, et al.
Published: (2022-11-01)

Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies
by: Valeria Internò, et al.
Published: (2023-02-01)

Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine
by: Audrey Mailliez, et al.
Published: (2014-08-01)

Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model
by: Claudia Tulotta, et al.
Published: (2016-02-01)

Systemic Immunotherapy for the Treatment of Brain Metastases
by: Justine V. Cohen, et al.
Published: (2016-03-01)

Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift
by: Edy Ippolito, et al.
Published: (2022-03-01)

An Institutional Retrospective Analysis of 93 Patients with Brain Metastases from Breast Cancer: Treatment Outcomes, Diagnosis-Specific Prognostic Factors
by: Delphine Antoni, et al.
Published: (2012-12-01)

Pre-operative stereotactic radiosurgery treatment is preferred to post-operative treatment for smaller solitary brain metastases
by: Hamidreza Aliabadi, et al.
Published: (2017-10-01)

Response of Brain and Meningeal Metastases to Trastuzumab-Deruxtecan in a Patient with HER2-Low Breast Cancer: A Case Report
by: Benita Wolf, et al.
Published: (2023-11-01)

Analysis of prognostic factors in patients with brain metastases affecting survival
by: Sweety Gupta, et al.
Published: (2022-11-01)

Immunotherapy in NSCLC Patients with Brain Metastases
by: Silvia Buriolla, et al.
Published: (2022-06-01)

Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
by: E V Artamonova, et al.
Published: (2015-06-01)

Brain metastases from rectal cancer – case report
by: Jakub Litak, et al.
Published: (2017-04-01)

Brain metastases from rectal cancer – case report
by: Jakub Litak, et al.
Published: (2017-04-01)

Particular aspects of cerebral metastases secondary to malignant melanoma in comparison with other brain metastases
by: Viorel Mihai Pruna, et al.
Published: (2015-12-01)

Molecular Mechanisms Driving the Formation of Brain Metastases
by: Bethany K. Campbell, et al.
Published: (2022-10-01)

Genomic and Transcriptomic Profiling of Brain Metastases
by: Christopher P. Wardell, et al.
Published: (2021-11-01)

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies
by: Dorien E.C.M. de Vocht, et al.
Published: (2023-09-01)

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
by: Sophie Katzendobler, et al.
Published: (2022-12-01)

MRI Findings of Brain Metastases in Lung Cancers
by: Ismail Okan Yildirim, et al.
Published: (2014-03-01)

Building Team Medicine in the Management of CNS Metastases
by: Archit B. Baskaran, et al.
Published: (2023-06-01)

Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits
by: Hui Wang, et al.
Published: (2023-06-01)

Evaluation of central nervous system metastases with immunohistochemistry correlation
by: Pranshuta Sharma, et al.
Published: (2014-01-01)

An Insight into Molecular Targets of Breast Cancer Brain Metastasis
by: Mohammed Kaleem, et al.
Published: (2022-10-01)

Linac-Based Radiosurgery for Patients With Brain Oligometastases From a Breast Primary, in the Trastuzumab Era-Impact of Tumor Phenotype and Prescribed SRS Dose
by: Kevin Armstrong, et al.
Published: (2019-05-01)

A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature
by: Sandipkumar H Patel, et al.
Published: (2021-01-01)